Adrian Kilcoyne
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Adrian Kilcoyne
Celularity Inc reported in an 8-K filed September 13, 2024 that Adrian Kilcoyne resigned as Executive Vice President and Chief Medical Officer, effective August 6, 2024. The proxy statement of Celularity Inc reports total compensation of $1,238,065 for Adrian Kilcoyne in fiscal 2023, including a base salary of $475,000. Disclosed compensation is on record for 2 fiscal years. Adrian Kilcoyne has spoken on 1 earnings call and 3 other investor events across 1 company, most recently for Cellectis S.A. on September 8, 2026.
“On July 24, 2024, Adrian Kilcoyne, M.D., M.P.H., M.B.A. of Celularity Inc., or Celularity, provided notice of resignation from his role as Executive Vice President and Chief Medical Officer, effective as of August 6, 2024, to pursue other opportunities.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Cellectis S.A. (CLLS)
Source not stated
Current -
Celularity Inc (CELU)
Proxy statement
CurrentStart not stated–present
-
Start not stated–2023-05-01
Last confirmed by a filing; no departure on record
Company network
Recorded roles and call appearances connecting this person to public companies.
CELU
Leadership on record at Celularity Inc
Other people whose current roles at this company are on record from its filings.
- Robert J. Hariri CEO, Board Member
- John Sprague CFO
- Joseph DosSantos CFO, Board Member
- Bradley Glover COO, CTO
- Bradley Glover, Ph.D. COO, CTO
- John R. Haines COO, Board Member
- Steven N. Gordon, Esq. COO, Board Member
- K. Harold Fletcher General Counsel
- Keary Dunn General Counsel
- Geoffrey Ling Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2023 | Celularity Inc (CELU) | M.D., M.P.H., M.B.A. Former Executive Vice President and Chief Medical Officer | $475,000 | $1,238,065 |
| 2022 | Celularity Inc (CELU) | M.D., M.P.H., M.B.A. Former Executive Vice President and Chief Medical Officer | $122,404 | $267,583 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.
-
-
Annual General Meeting Cellectis Reports Results from Shareholders Meeting Held on June 25, 2026 Cellectis S.A. (CLLS)
-
Annual General Meeting Cellectis’ Annual Shareholders General Meeting to be Held on June 25, 2026 Cellectis S.A. (CLLS)
-
-